We are live on
!
Find out more
MIG
McGuire Investment Group Portfolio holdings
AUM
$1.14B
1-Year Est. Return
79.59%
This Fund
S&P 500
This Quarter
Est. Return
+10.14%
1 Year Est. Return
+79.59%
3 Year Est. Return
+184.19%
5 Year Est. Return
+218.18%
10 Year Est. Return
–
AUM
$527M
AUM Growth
+$53M
(+11%)
Cap. Flow
+$8.1M
Cap. Flow
% of AUM
1.54%
Top 10 Holdings %
Top 10 Hldgs %
39.01%
Holding
119
New
10
Increased
34
Reduced
55
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
First Trust NYSE Arca Biotechnology Index Fund
FBT
|
+$5.1M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$3.44M |
| 3 |
Invesco S&P SmallCap Health Care ETF
PSCH
|
+$2.49M |
| 4 |
State Street SPDR S&P Biotech ETF
XBI
|
+$2.19M |
| 5 |
Invesco S&P SmallCap Information Technology ETF
PSCT
|
+$945K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Altimmune
ALT
|
+$2.73M |
| 2 |
Cboe Global Markets
CBOE
|
+$950K |
| 3 |
Biogen
BIIB
|
+$503K |
| 4 |
Apple
AAPL
|
+$476K |
| 5 |
FedEx
FDX
|
+$431K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.13% |
| 2 | Healthcare | 26.74% |
| 3 | Financials | 10.23% |
| 4 | Industrials | 4.1% |
| 5 | Consumer Staples | 2.39% |
Similar funds
BBP
PFCS
SL
MIC
ACM
HMCP
OHIF
WM
McGuire Investment Group's Q2 2021 Portfolio in Review
As of Q2 2021, McGuire Investment Group held 119 positions worth $527M, up 11% from $474M the previous quarter. Its ten largest holdings account for 39% of the portfolio.
McGuire Investment Group's Q2 2021 filing shows 10 new, 34 increased, 55 reduced and 3 closed positions. Its largest new stake was First Trust NYSE Arca Biotechnology Index Fund: 30,898 shares worth $5.33M. The largest sale was Altimmune, an estimated $2.73M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 30% a quarter earlier, followed by Healthcare and Financials.
- McGuire Investment Group's largest Q2 2021 buy was First Trust NYSE Arca Biotechnology Index Fund: 30,898 shares worth $5.33M.
- McGuire Investment Group added most to State Street SPDR S&P Biotech ETF in Q2 2021, an estimated $2.19M increase.
- McGuire Investment Group's biggest Q2 2021 reduction was Cboe Global Markets, cutting an estimated $950K.
- McGuire Investment Group fully exited Altimmune in Q2 2021, selling an estimated $2.73M.
- McGuire Investment Group's ten largest holdings make up 39% of its $527M portfolio in Q2 2021.
- McGuire Investment Group opened 10 new positions and closed 3 in Q2 2021.
- McGuire Investment Group's portfolio value rose 11% quarter-over-quarter to $527M.
Based on McGuire Investment Group's 13F filing for Q2 2021, filed 16 Jul 2021.